Cerebrolysin Peptide Therapy
Benefits, Side Effects, Cost & Protocols
Cerebrolysin is a mixture of enzymatically-treated peptides derived from pig brain containing brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF). It is used as a therapy for brain diseases in dozens of countries across Eurasia.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is Cerebrolysin Best For?
How Cerebrolysin Works
Contains neurotrophic factors that may support neuronal survival, synaptic plasticity, and neurogenesis.
Cerebrolysin FAQ
What is CEREBROLYSIN?
Cerebrolysin is a mixture of peptides and amino acids derived from pig brain tissue, researched extensively for neurotrophic and neuroprotective effects, particularly in cognitive recovery.
How does CEREBROLYSIN work?
Contains neurotrophic factors that may support neuronal survival, synaptic plasticity, and neurogenesis.
Is CEREBROLYSIN legal to buy?
CEREBROLYSIN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy CEREBROLYSIN?
CEREBROLYSIN has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does CEREBROLYSIN belong to?
CEREBROLYSIN is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.
What are the research benefits of CEREBROLYSIN?
CEREBROLYSIN has been studied for: Cognitive support, Brain recovery, Neuroprotection, Memory research. Neurotrophic factors; brain recovery research.
Key Studies
662 total on PubMed339 human trials[Effects of simultaneous use of Cerebrolysin and alteplase on hemorrhagic transformation of brain infarction and functional outcome in stroke patients: CEREHETIS, a randomized, multicenter pilot trial]
Zh Nevrol Psikhiatr Im S S Korsakova · Zh Nevrol Psikhiatr Im S S KorsakovaRCT
14 days treatment, 90 days follow-up
Cerebrolysin with alteplase reduced symptomatic hemorrhagic transformation but showed no functional benefit at 90 days
[Cerebrolysin and the optimal timing of anticoagulation resumption in stroke: combined post hoc survival analysis of the CEREHETIS trial]
Zh Nevrol Psikhiatr Im S S Korsakova · Zh Nevrol Psikhiatr Im S S KorsakovaPhase 3
Cerebrolysin reduced hemorrhagic transformation risk and enabled earlier anticoagulation resumption in stroke.
Cerebrolysin reduced hemorrhagic transformation risk and enabled earlier anticoagulation resumption in stroke
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
Alvarez XA, Cacabelos R, Sampedro C et al
Eur J NeurolPhase 2
Cerebrolysin at all three dosages improved global clinical function and cognition in moderate to moderately severe Alzheimer's disease.
Cerebrolysin at all three dosages improved global clinical function and cognition in moderate to moderately severe Alzheimer's disease
Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
Muresanu DF, Heiss WD, Hoemberg V et al
StrokePhase 3
Cerebrolysin significantly improved motor function in upper extremities at day 90 post-stroke vs placebo
Cerebrolysin News
Cerebrolysin IV Therapy Now Available at NexGen Health in Silicon Valley - Yahoo Finance
Yahoo Finance · 8 months ago
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study - American Heart Association Journals
American Heart Association Journals · 15 months ago
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin - Wiley Online Library
Wiley Online Library · 37 months ago
Old Drug a New Option for Stroke-Related Aphasia? - Medscape
Medscape · 18 months ago
Everything You Need to Know About the FDA Peptide Ban - Hone Health
Hone Health · 26 months ago
The under-the-radar injections people are taking to build muscle this summer — including the 'Wolverine' shot - Business Insider
Business Insider · 9 months ago
Use of Cerebrolysin in combination with high-dose aspirin antithrombotic treatment of ischemic stroke: A case report - Wiley Online Library
Wiley Online Library · 56 months ago
Frankenfooty: Essendon’s mixed bag of supplements - The Conversation
The Conversation · 155 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Cerebrolysin with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Cerebrolysin.
Take the Quiz →